ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunosuppression"

  • 2016 American Transplant Congress

    Early Steroid Withdrawal in African American Kidney Transplant Recipients: A Propensity Score Matching Analysis.

    D. Taber, M. Gebregziabher, T. Srinivas, K. Chavin, P. Baliga, L. Egede.

    MUSC, Charleston, SC.

    Objective: The aim of this study was to assess the safety of steroid withdrawal in African American (AA) kidney transplant (KTX) recipients.Methods: Longitudinal cohort study…
  • 2016 American Transplant Congress

    ABO-Incompatible Living Kidney Transplantation at Multicenter Japanese Case Series: Evolution of Outcomes and Immunosuppressive Management.

    K. Tanabe,1 M. Okumi,1 M. Furusawa,1 K. Unagami,1 T. Hirai,1 H. Shirakawa,2 T. Shimizu,1 K. Omoto,3 M. Inui,1 H. Ishida.1

    1Urology, Tokyo Women's Medical University, Tokyo, Japan; 2Urology, Ohkubo Hospital, Tokyo, Japan; 3Urology, Todachuo General Hospital, Saitama, Japan.

    [lsaquo]Background[rsaquo]ABO-incompatible living kidney transplantation (ABO-ILKT) has been performed to broaden the range of donor types used for living related kidney transplantation (LKT). Recently, ABO-ILKT has…
  • 2016 American Transplant Congress

    The Impact of a Novel Dual Adenosine Triphosphate-Competitive mTOR Inhibitor (TORKinib) on Alloimmunity and Transplant Survival.

    D. Fantus,1 Y. Ono,1 S. Yokota,1 C. Komatsu,1 H. Turnquist,1,2 A. Thomson.1,2

    1Surgery, Thomas E Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA; 2Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

    Background: Rapamycin (RAPA), an immunosuppressive agent, inhibits the mechanistic target of Rapamycin (mTOR), the kinase subunit of two mTOR- containing complexes (mTORC1 and mTORC2). While…
  • 2016 American Transplant Congress

    TRANSFORM: A Modern Approach to Evaluate Long-Term Outcomes of Everolimus with Reduced-Calcineurin Inhibitors in De Novo Kidney Transplant Recipients[mdash]Baseline Characteristics.

    M. Henry.

    On behalf of the TRANSFORM Investigators, Division of Transplantation Surgery, Wexner Medical Center, The Ohio State University, Columbus, OH.

    Purpose: Acute rejection and poor graft function are two major risk factors for allograft failure in kidney transplant (KTx) recipients (KTxR). Although, graft survival and…
  • 2016 American Transplant Congress

    An Epidemiological Update of Non-Melanoma Skin Cancer in Immunosuppressed Organ Transplant Recipients with Skin of Color.

    C. Shaver, C. Cusack, C. Chung.

    Dermatology, Drexel University College of Medicine, Philadelphia, PA.

    Introduction:It is predicted by the US census that by year 2050, minorities will become the majority US population. We know skin cancer in patients with…
  • 2016 American Transplant Congress

    Patients with ESRD Due to Diabetes Have Higher Variability of Their Tacrolimus Levels and Worse Outcomes.

    D. Goodall, M. Willicombe, A. McLean, D. Taube.

    Imperial College Renal and Transplant Centre, Imperial College NHS Trust, London, United Kingdom.

    IntroductionNonadherence to immunosuppressants is associated with rejection and graft loss and nonadherence to antidiabetics is associated with poor glycaemic control leading to microvascular complications and…
  • 2016 American Transplant Congress

    Two-Year Safety Results from the Phase 3b Switching Study of Kidney Transplant Patients with Tremor to LCP-Tacro (STRATO) Study.

    S. Steinberg,1 R. Gedaly,2 L. Chan,3 A. Langone.4

    1California Institute of Renal Research, San Diego; 2University of Kentucky Medical Center, Lexington; 3University of Colorado, Aurora; 4Vanderbilt University Medical Center, Nashville.

    Tremor is a common side effect of tacrolimus (tac) correlated with peak-dose drug concentration. Envarsus XR®, a novel, once-daily, extended-release formulation of tac, has a…
  • 2016 American Transplant Congress

    What if Mycophenolic Acid Product Is Discontinued Less Than 6 Weeks Before Pregnancy?

    N. Sifontis,1 L. Coscia,2 D. Armenti,2 S. Constantinescu,2,3 M. Moritz.2,4

    1Pharmacy Practice, Temple University, Philadelphia, PA; 2Gift of Life Institute, National Transplantation Pregnancy Registry (NTPR), Philadelphia, PA; 3Medicine, Temple University, Philadelphia, PA; 4Surgery, Lehigh Valley Health Network, Allentown, PA.

    It is recommended that mycophenolic acid (MPA) products be discontinued at least 6 wks prior to conceiving due to potential teratogenic effects and increase risk…
  • 2016 American Transplant Congress

    Evaluation of the Major Adverse Cardiac Events Risk with Everolimus-Based Calcineurin Inhibitor Reduction or Withdrawal Regimen in Liver Transplant Recipients: 3-Year Post-Hoc Analysis of the Randomized H2304 Extension Study.

    P. Bernhardt,1 G. Dong,2 P. Lopez,1 G. Hustache,1 G. Bader.1

    1Novartis Pharma AG, Basel, Switzerland; 2Novartis Pharmaceuticals Corporation, East Hannover.

    Purpose:Cardiovascular disease (CVD) is one of the leading causes of death in liver transplant recipients (LTxRs). Impaired glomerular filtration rate (GFR) is a risk factor…
  • 2016 American Transplant Congress

    2B4 Over-Expression Impairs Donor-Reactive CD8+ T Cell Proliferation and Accumulation Following Transplantation.

    S. Laurie, D. Liu, M. Ford.

    Emory Transplant Center, Emory University School of Medicine, Atlanta, GA.

    T cell function is tightly regulated by a fine balance of coinhibitory signals, including those transduced by 2B4 (SLAMf4, CD244), an immunoglobulin-superfamily member constitutively expressed…
  • « Previous Page
  • 1
  • …
  • 102
  • 103
  • 104
  • 105
  • 106
  • …
  • 138
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences